RTW INVESTMENTS, LP Q3 2018 Filing
Filed November 14, 2018
Portfolio Value
$1.7T
Holdings
46
Report Date
Q3 2018
Filing Type
13F-HR
All Holdings (46 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | RCKTRocket Pharmaceuticals Inc | 14,969,744 | $368.6B | 22.07% | |
| 2 | PTCTPTC Therapeutics Inc | 3,275,591 | $154.0B | 9.22% | |
| 3 | ARWRARROWHEAD PHARMACEUTICALS IN | 7,604,225 | $145.8B | 8.73% | |
| 4 | RGNXRegenxbio Inc | 1,459,128 | $110.2B | 6.60% | |
| 5 | —Dicerna Pharmaceuticals Inc | 5,461,124 | $83.3B | 4.99% | |
| 6 | PRQRPROQR THRAPEUTICS N V | 3,739,406 | $72.4B | 4.33% | |
| 7 | BMYBRISTOL MYERS SQUIBB CO | 946,961 | $58.8B | 3.52% | |
| 8 | LIVNLivaNova PLC | 443,036 | $54.9B | 3.29% | |
| 9 | SRPTSarepta Therapeutics Inc | 314,070 | $50.7B | 3.04% | |
| 10 | —ACHILLION PHARMACEUTICALS IN | 13,595,704 | $50.0B | 3.00% | |
| 11 | 3M4Masimo Corp | 310,461 | $38.7B | 2.31% | |
| 12 | I9DNArbutus Biopharma Corp | 4,084,904 | $38.6B | 2.31% | |
| 13 | —CORIUM INTL INC | 3,610,632 | $34.3B | 2.06% | |
| 14 | ALNYAlnylam Pharmaceuticals Inc | 389,072 | $34.1B | 2.04% | |
| 15 | VRAYQViewray Inc | 3,389,498 | $31.7B | 1.90% | |
| 16 | VCELVericel Corp | 2,217,916 | $31.4B | 1.88% | |
| 17 | ILMNIllumina Inc | 82,621 | $30.3B | 1.82% | |
| 18 | —Qiagen NV | 775,324 | $29.4B | 1.76% | |
| 19 | —La Jolla Pharmaceutical Co | 1,197,107 | $24.1B | 1.44% | |
| 20 | AGENEURAgenus Inc | 9,824,579 | $21.0B | 1.26% | |
| 21 | ESTAESTABLISHMENT LABS HLDGS INC | 775,809 | $18.1B | 1.08% | |
| 22 | —Myokardia Inc | 273,917 | $17.9B | 1.07% | |
| 23 | —Principia Biopharma Inc | 644,448 | $17.4B | 1.04% | |
| 24 | RMEResMed Inc | 147,400 | $17.0B | 1.02% | |
| 25 | —Bovie Medical Corp | 2,235,547 | $15.9B | 0.95% | |
| 26 | QUREUniqure NV | 428,980 | $15.6B | 0.93% | |
| 27 | SLDBSolid Biosciences Inc | 262,318 | $12.4B | 0.74% | |
| 28 | PACBPACIFIC BIOSCIENCES CALIF IN | 2,237,607 | $12.1B | 0.72% | |
| 29 | CDNACareDx Inc | 357,766 | $10.3B | 0.62% | |
| 30 | FIXXEURHomology Medicines Inc | 434,917 | $9.9B | 0.60% | |
| 31 | VKTXViking Therapeutics Inc | 500,000 | $8.7B | 0.52% | |
| 32 | —VIVEVE MED INC | 3,147,232 | $8.4B | 0.51% | |
| 33 | ECORGBPELECTROCORE INC | 514,165 | $7.2B | 0.43% | |
| 34 | —Odonate Therapeutics Inc | 289,608 | $5.6B | 0.34% | |
| 35 | —Nuvectra Corp | 251,329 | $5.5B | 0.33% | |
| 36 | NVAXNovavax Inc | 2,771,023 | $5.2B | 0.31% | |
| 37 | STIMNeuronetics Inc | 157,487 | $5.0B | 0.30% | |
| 38 | —VIVUS INC | 4,000,000 | $3.2B | 0.19% | |
| 39 | —PROTEOSTASIS THERAPEUTICS IN | 1,129,121 | $2.7B | 0.16% | |
| 40 | ARGXARGENX SE | 26,853 | $2.0B | 0.12% | |
| 41 | —RA MED SYS INC | 110,000 | $2.0B | 0.12% | |
| 42 | —Tapimmune Inc | 209,721 | $1.9B | 0.11% | |
| 43 | —Novus Therapeutics Inc | 316,257 | $1.5B | 0.09% | |
| 44 | ADVMCHFAdverum Biotechnologies Inc | 184,821 | $1.1B | 0.07% | |
| 45 | —Bellicum Pharmaceuticals Inc | 157,489 | $970.0M | 0.06% | |
| 46 | —MOTUS GI HLDGS INC | 59,478 | $303.0M | 0.02% |